Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.5 SEK | +0.98% |
|
+2.28% | +81.30% |
27/06 | Hansa Biopharma AB Announces Board Appointments | CI |
31/05 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HANSA BIOPHARMA AB | Other Biotechnology & Medical Research | +0.98% | +2.28% | +81.30% | +6.17% | -73.58% | 304M | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- HNSA Stock
- Charts Hansa Biopharma AB
- Comparison Chart